Antiphospholipid antibodies (aPL) are a group of autoantibodies that target phospholipids and phospholipid-binding proteins, leading to an increased risk of thrombosis and pregnancy complications. Their detection is crucial in diagnosing antiphospholipid syndrome (APS), a condition associated with recurrent venous or arterial thrombosis and obstetric complications such as preeclampsia or fetal loss. Understanding aPL is essential for effective management and prevention of these serious outcomes.

Please confirm you want to block this member.
You will no longer be able to:
Please allow a few minutes for this process to complete.